Drug Type Monoclonal antibody |
Synonyms Research programme: fibrosis and organ failure therapeutics - Biogen, fibrosis and organ failure therapeutics(The University of California, San Francisco) |
Target |
Mechanism αvβ5 antagonists(Integrin alpha-V/beta-5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fibrosis | Preclinical | US | 30 Nov 2010 | |
Multiple Organ Failure | Preclinical | US | 30 Nov 2010 |